Azoles Targeting Recurrent High Grade Gliomas

Clinical trial NCT03763396 · NOT_YET_RECRUITING

Trial details

NCT number: NCT03763396
Sponsor: University Health Network, Toronto
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Brain Tumor, Recurrent Cancer, Advanced Glioma of Brain

Start date: 2024-06-01
Primary completion: 2025-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.